# EDGAR Filing Document

**Accession Number:** 0002069604
**File Stem:** 0002088869-25-000008
**Filing Date:** 2025-12
**Character Count:** 9692
**Document Hash:** b1b56b6cdfb9fbafe2fab302d92888c8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002088869-25-000008.hdr.sgml**: 20251202

**ACCESSION NUMBER**: 0002088869-25-000008

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251202

**FILED AS OF DATE**: 20251202

**DATE AS OF CHANGE**: 20251202

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Steele Christopher Eugene
- **CENTRAL INDEX KEY:** 0002089998

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42967
- **FILM NUMBER:** 251544470

**MAIL ADDRESS:**
- **STREET 1:** 6455 TANAGERS PT.
- **CITY:** EXCELSIOR
- **STATE:** MN
- **ZIP:** 55331
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Park Dental Partners, Inc.
- **CENTRAL INDEX KEY:** 0002069604
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 932020683
- **STATE OF INCORPORATION:** MN
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2200 COUNTY ROAD C WEST
- **STREET 2:** SUITE 2210
- **CITY:** ROSEVILLE
- **STATE:** MN
- **ZIP:** 55113
- **BUSINESS PHONE:** 6516330500

**MAIL ADDRESS:**
- **STREET 1:** 2200 COUNTY ROAD C WEST
- **STREET 2:** SUITE 2210
- **CITY:** ROSEVILLE
- **STATE:** MN
- **ZIP:** 55113

## Ex-24

```

POWER OF ATTORNEY The undersigned, in his or her capacity as a director or
officer of Park Dental Partners, Inc. (the "Company"), constitutes and appoints
Maxwell Black of Winthrop & Weinstine, P.A. as his or her true and lawful
attorney-in-fact, with full power of substitution, to: (a) execute for and on
behalf of the undersigned, in the undersigned's capacity as a director or
officer of the Company, Forms 3, 4 and 5 (and any amendments thereto) required
to be filed by the undersigned under Section 16 of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), and the rules and regulations
thereunder; (b) prepare, execute and file, for and on behalf of the
undersigned, Schedules 13D and 13G (and any amendments thereto), together with
any related exhibits, cover pages, certifications and documents, including any
joint filing agreements, required to be filed by the undersigned under Section
13 of the Exchange Act, and the rules and regulations thereunder; (c) prepare,
execute and file for and on behalf of the undersigned electronic Forms 144 (and
any amendments thereto), together with any related certifications or documents
reasonably necessary to effect such filings; (d) prepare, execute and submit,
on the undersigned's behalf, Form ID applications, updates, and renewals, and
take any actions reasonably necessary to obtain, maintain, recover or' update
Electronic Data Gathering, Analysis, and Retrieval ("EDGAR") access credentials
for the undersigned, including Central Index Key ("CIK") assignment, access
codes, passphrases, multi-factor authentication and role designations under
EDGAR Next; (e) cause the Company to accept a delegation of authority from any
of the undersigned's EDGAR account administrators and, pursuant to that
delegation, authorize the Company's EDGAR account administrators to appoint,
remove or replace users for the undersigned's EDGAR account; (f) do and perform
any and all acts for and on behalf of the undersigned which may be necessary or
desirable to complete, file and submit the foregoing documents with the U.S.
Securities and Exchange Commission through the EDGAR system, including
coordinating with the Company, its transfer agent, equity plan administrator,
and brokers (each as applicable) to obtain holdings and transaction
information, and preparing, submitting and correcting any amendments; and (g)
take any other action of any type whatsoever in connection with the foregoing
that, in the opinion of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the undersigned, it being understood
that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in his
discretion consistent with the scope of authority granted herein. The
undersigned hereby grants to the attorney-in-fact full power and authority to
do and perform any act necessary and proper to be done in the exercise of any
of the rights and powers herein granted, as fully to all intents and purposes
as the undersigned might or could do personally, with full power of
substitution or revocation, hereby ratifying and confirming all that the
attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause
to be done by virtue of this Power of Attorney and the rights and powers herein
granted. This Power of Attorney is limited to the purposes described above and
does not authorize the attorney-in-fact to take any action on behalf of the
undersigned other than with respect to the preparation, execution and filing of
Schedules 13D and 13G, Forms 3, 4 and 5, electronic Forms 144, and Form ID and
associated EDGAR Next account administration, and actions reasonably incidental
thereto (including the use and retention of electronic signatures and approvals
in compliance with Regulation S-T). Nothing herein authorizes the
attorney-in-fact to make investment decisions, execute trades, or direct the
undersigned's brokerage accounts. This Power of Attorney shall remain in full
force and effect until revoked by the undersigned in a signed writing delivered
to the attorney-in-fact. This Power of Attorney may be executed in
counterparts, each of which shall be deemed an original, and all of which
together shall constitute one and the same instrument. Signatures delivered by
electronic transmission (including any electronic signature compliant with
Regulation S-T) shall be deemed original for all purposes. IN WITNESS WHEREOF,
the undersigned has caused this Power of Attorney to be executed as of this
22nd day of October, 2025. Signed by: /s/ Christopher Steele

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Steele Christopher Eugene<br><sub>(Last) (First) (Middle)</sub><br>6455 TANAGERS PT.<br><sub>(Street)</sub><br>EXCELSIOR, MN 55331<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Park Dental Partners, Inc. [ PARK ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-12-02 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock<sup>(1)</sup> | 137172 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Includes 119,922 shares of restricted stock issued to the Reporting Person (the "Restricted Stock"), which shares vest as follows: (i) 25% on the completion of the Issuer's initial public offering; and (ii) thereafter, at the rate of 6.25% per quarter. The Restricted Stock is subject to accelerated vesting in connection with a change in control of the Issuer in accordance with the terms of the Park Dental Partners, Inc. 2023 Restricted Stock Plan and the applicable award agreement. The Restricted Stock does not confer any voting rights until the applicable shares have vested and the holder of Restricted Stock has become the record owner of such vested shares.

**Signature:** Maxwell Black as Attorney-in-Fact for Christopher Steele  
**Date:** 2025-12-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**